ResMed 2024 Investor Day: What’s Coming on September 30
ResMed will meet with investors on September 30 at the New York Stock Exchange for its 2024 Investor Day. The goal is straightforward: share how the company plans to accelerate growth and execute on its strategy, and give attendees a clear view of what’s next.
What to Expect on the Day
The program is scheduled to begin around 1:00 p.m. Eastern Daylight Time. You can join in person at the NYSE or watch via a live webcast, so participation isn’t limited by location. During the event, ResMed plans to outline its transformative strategy and its vision for 2030—how the company aims to scale its impact and support better care across the healthcare ecosystem.
Innovation at the Core
ResMed’s strategy centers on digital health. The company builds cloud-connected medical devices that help treat conditions such as sleep apnea and COPD, with tools designed to support patients and the clinicians who care for them. By focusing on out-of-hospital care, these solutions help lower the need for hospital admissions and support people in managing their health day to day.
Why Digital Health Matters
Digital platforms make it possible to tailor care to each person. With connected devices and software working together, providers can monitor progress, adjust treatment, and keep patients engaged. ResMed is active in this space across more than 140 countries, applying what it learns to improve products and services over time.
Priorities, Roadmap, and Growth
At Investor Day, ResMed intends to discuss where it’s investing, what capabilities it’s strengthening, and how those choices translate into outcomes for patients and providers. Expect context on technology enhancements, product development, and areas where partnerships could help the company grow and deliver more value.
The Investment Lens
As a player in healthcare technology, ResMed’s work sits at the intersection of hardware, software, and clinical practice. For investors, the event offers a consolidated view of how the company plans to compete, how digital health trends shape its decisions, and how those choices align with its operating philosophy.
Who Will Benefit from Attending
This event is relevant for investors, analysts, and anyone tracking the future of healthcare technology. You’ll hear directly from the company about priorities, progress, and plans—how ResMed expects to advance its products and services to better support patients and the clinicians and organizations that care for them.
Registration and Access
Details on how to register will be shared ahead of the event. Attendance will be available both in person and online via webcast, with a process designed to be straightforward for all participants.
Contact Information
If you have questions about the event or investor relations, ResMed’s team can help. For investor-specific inquiries, call +1 858.836.5000 or email investorrelations@resmed.com. For media inquiries, call +1 619.510.1281 or email news@resmed.com.
Frequently Asked Questions
What’s the main purpose of ResMed’s Investor Day?
To share the company’s strategy and growth plans with investors and stakeholders, including how its digital health approach supports long-term execution.
When does the event start, and where is it held?
The event takes place on September 30 and is scheduled to begin around 1:00 p.m. EDT at the New York Stock Exchange, with a webcast available.
How can I attend?
You can join in person at the NYSE or participate via a live webcast. Registration details will be provided in advance of the event.
What topics will be covered?
Expect updates on ResMed’s 2030 vision, digital health initiatives, and product and technology priorities aimed at improving patient outcomes.
Who can I contact for more information?
For investor-related questions, call +1 858.836.5000 or email the investor relations team. For media inquiries, call +1 619.510.1281.
